Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study

Genome-Wide Association Study of Prognosis in Advanced Non-Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

(2012) L. Hu et al.   CLINICAL CANCER RESEARCH

First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung

(2012) Ji-Youn Han et al.   JOURNAL OF CLINICAL ONCOLOGY

Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer

(2012) M. Crous-Bou et al.   MUTAGENESIS

DNA Methylation Suppresses Expression of the Urea Cycle Enzyme Carbamoyl Phosphate Synthetase 1 (CPS1) in Human Hepatocellular Carcinoma

(2011) Hongyan Liu et al.   AMERICAN JOURNAL OF PATHOLOGY

Common genetic variants in cell cycle pathway are associated with survival in stage III–IV non-small-cell lung cancer

(2011) Jikai Yin et al.   CARCINOGENESIS

Exome sequencing and subsequent association studies identify five amino acid-altering variants influencing human height

(2011) Jae-Jung Kim et al.   HUMAN GENETICS

Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

(2011) Xifeng Wu et al.   JNCI-Journal of the National Cancer Institute

Integrative Genomic Profiling of Human Prostate Cancer

(2010) Barry S. Taylor et al.   CANCER CELL

A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population

(2010) Kyong-Ah Yoon et al.   HUMAN MOLECULAR GENETICS

Genome-Wide Association Study on Overall Survival of Advanced Non-small Cell Lung Cancer Patients Treated with Carboplatin and Paclitaxel

(2010) Yasunori Sato et al.   Journal of Thoracic Oncology

Assessment of XPD Lys751Gln and XRCC1 T–77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy

(2010) Li Liu et al.   LUNG CANCER

Genome-Wide Association Study of Pancreatic Cancer in Japanese Population

(2010) Siew-Kee Low et al.   PLoS One

Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival

(2009) K Einarsdóttir et al.   BRITISH JOURNAL OF CANCER

EGFR pathway polymorphisms and bladder cancer susceptibility and prognosis

(2009) R. A. Mason et al.   CARCINOGENESIS

Epidermal Growth Factor Genetic Variation, Breast Cancer Risk, and Waiting Time to Onset of Disease

(2009) Ana Paula Araújo et al.   DNA AND CELL BIOLOGY

Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first‐line chemotherapy with second‐line crossover in patients with advanced nonsmall cell lung cancer

(2008) Ji‐Youn Han et al.   CANCER

Pathway-based evaluation of 380 candidate genes and lung cancer susceptibility suggests the importance of the cell cycle pathway

(2008) H.Dean Hosgood et al.   CARCINOGENESIS

ETV6-NCOA2: A Novel Fusion Gene in Acute Leukemia Associated with Coexpression of T-Lymphoid and Myeloid Markers and Frequent NOTCH1 Mutations

(2008) S. Strehl et al.   CLINICAL CANCER RESEARCH

A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene

(2008) S. Gobeil et al.   GENES & DEVELOPMENT

Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor β1 -509C>T gene polymorphisms with gallbladder cancer

(2008) Monika Vishnoi et al.   HUMAN IMMUNOLOGY

Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases

(2008) A Murati et al.   LEUKEMIA

Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy

(2008) Xifeng Wu et al.   Pharmacogenetics and Genomics